ReviewInternational journal of molecular sciences2022

Targeting Fibronectin to Overcome Remyelination Failure in Multiple Sclerosis: The Need for Brain- and Lesion-Targeted Drug Delivery.

Pauline E M van Schaik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.